MORGANTOWN – Protea Biosciences Group Inc., has been selected by The Scientist, an international research journal of the Life Sciences industry, to receive its Top Ten Innovative Technologies award for the year 2011.
In the January 2012 issue, The Scientist selected Protea’s LAESI DP-1000, a new instrument developed by Protea that eliminates time-consuming sample preparation steps, and allows rapid molecular analysis of biological samples.
“On behalf of our employees, shareholders and customers, we thank The Scientist for its selection of LAESI DP-1000, which we believe is a game-changing life sciences instrument, that has the potential to dramatically accelerate and reduce the costs of biomedical discovery”, said Steve Turner, Protea’s CEO. He added, “Through Protea, West Virginia is creating world-class biotechnology and successfully competing in the global biosciences sector.”
LAESI technology was invented in the laboratory of Akos Vertes, PhD., George Washington University, and exclusively licensed to Protea. Using the LAESI DP-1000 instrument developed by Protea, large numbers of biomolecules can be rapidly identified and spatially mapped via imaging to cell structures, and tissues.
“What makes the LAESI DP-1000 unique is that it is a universal platform - one that can be used to analyze all types of biological samples, including tissue biopsies, live cells, blood, and other biofluids,” Turner said. “It allows the direct, molecular analysis of living cells.”
The Scientist is an International print and digital publication, dedicated to covering a wide range of topics central to the study of cell and molecular biology, genetics, and other life-science fields.
Protea is a leader in the field of bioanalytics - the identification and analysis of proteins and other biomolecules that are produced by living cells, technology that is essential to pharmaceutical and medical research.
No comments:
Post a Comment